全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

The Geographic Distribution of Loa loa in Africa: Results of Large-Scale Implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)

DOI: 10.1371/journal.pntd.0001210

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Loiasis is a major obstacle to ivermectin treatment for onchocerciasis control and lymphatic filariasis elimination in central Africa. In communities with a high level of loiasis endemicity, there is a significant risk of severe adverse reactions to ivermectin treatment. Information on the geographic distribution of loiasis in Africa is urgently needed but available information is limited. The African Programme for Onchocerciasis Control (APOC) undertook large scale mapping of loiasis in 11 potentially endemic countries using a rapid assessment procedure for loiasis (RAPLOA) that uses a simple questionnaire on the history of eye worm. Methodology/Principal Findings RAPLOA surveys were done in a spatial sample of 4798 villages covering an area of 2500×3000 km centred on the heartland of loiasis in Africa. The surveys showed high risk levels of loiasis in 10 countries where an estimated 14.4 million people live in high risk areas. There was a strong spatial correlation among RAPLOA data, and kriging was used to produce spatially smoothed contour maps of the interpolated prevalence of eye worm and the predictive probability that the prevalence exceeds 40%. Conclusion/Significance The contour map of eye worm prevalence provides the first global map of loiasis based on actual survey data. It shows a clear distribution with two zones of hyper endemicity, large areas that are free of loiasis and several borderline or intermediate zones. The surveys detected several previously unknown hyperendemic foci, clarified the distribution of loiasis in the Central African Republic and large parts of the Republic of Congo and the Democratic Republic of Congo for which hardly any information was available, and confirmed known loiasis foci. The new maps of the prevalence of eye worm and the probability that the prevalence exceeds the risk threshold of 40% provide critical information for ivermectin treatment programs among millions of people in Africa.

References

[1]  Kershaw WE, Keay RWJ, Nicholas WL, Zahra A (1953) Studies on the epidemiology of filariasis in West Africa with special reference to the British Cameroons and the Niger delta. IV The incidence of Loa loa and Acanthocheilonema perstans in the rain-forest the forest fringe and the mountain grasslands of the British Cameroons with observations on the species of Chrysops and Culicoides fauna. Ann Trop Med Parasitol 47: 406–425.
[2]  Sasa M (1976) Human filariasis. A global survey of epidemiology and control. Univ Park Press Tokyo. 819 p.
[3]  Fain A (1978) [Current problems of loaiasis]. Bull World Health Organ 56: 155–167.
[4]  Hawking F (1977) The distribution of human filariasis throughout the world. Part III. Africa. Trop Dis Bull 74: 649–679.
[5]  Remme JHF, Boatin B, Boussinesq M (2008) Helminthic Diseases: Onchocerciasis and Loiasis. In: Heggenhougen HK, Quah S, editors. International Encyclopedia of Public Health. San Diego: Academic Press. pp. 339–351.
[6]  Duke BOL (1955) Symposium on loiasis. IV The development of Loa in flies of the genus Chrysops and the probable significance of the different species in the transmission of loiasis. Trans R Soc Trop Med Hyg 49: 115–121.
[7]  Boussinesq M (2006) Loiasis. Annals of Tropical Medicine and Parasitology 100: 715–731. doi: 10.1179/136485906X112194
[8]  Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC (1996) Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitol Today 12: 448–450. doi: 10.1016/0169-4758(96)40006-0
[9]  Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, et al. (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350: 18–22. doi: 10.1016/S0140-6736(96)11094-1
[10]  Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, et al. (1998) Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg 58: 461–469.
[11]  Boussinesq M, Gardon J, Kamgno J, Pion SD, Gardon-Wendel N, et al. (2001) Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Ann Trop Med Parasitol 95: 495–507. doi: 10.1080/00034980120073184
[12]  Boussinesq M, Gardon J (1997) Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Ann Trop Med Parasitol 91: 573–589. doi: 10.1080/00034989760671
[13]  Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH (2000) Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 356: 1077–1078. doi: 10.1037/h0046134
[14]  Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, et al. (2004) Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J 3: 7. doi: 10.1186/1475-2883-3-7
[15]  Diggle PJ, Thomson MC, Christensen OF, Rowlingson B, Obsomer V, et al. (2007) Spatial modelling and the prediction of Loa loa risk: decision making under uncertainty. Ann Trop Med Parasitol 101: 499–509. doi: 10.1179/136485907X229121
[16]  Tekle AH, Zoure H, Wanji S, Leak S, Noma M, et al. (2010) Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: Impact on control strategies. Acta Trop. doi: 10.1016/j.actatropica.2010.05.008
[17]  Toure FS, Kassambara L, Williams T, Millet P, Bain O, et al. (1998) Human occult loiasis: improvement in diagnostic sensitivity by the use of a nested polymerase chain reaction. Am J Trop Med Hyg 59: 144–149.
[18]  Burbelo PD, Ramanathan R, Klion AD, Iadarola MJ, Nutman TB (2008) Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection. J Clin Microbiol 46: 2298–2304. doi: 10.1128/JCM.00490-08
[19]  Wanji S (2001) Rapid assessment procedures for loiasis: report of a multi-centre study. Geneva: UNDP/World bank/WHO Special Programme for Research & Training in Tropical Diseases. 38 p. TDR/IDE/RP/RAPL/01.1 TDR/IDE/RP/RAPL/01.1.
[20]  Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, et al. (2002) Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ 80: 852–858.
[21]  TDR (2004) Three simple questions speed up the fight against river blindness. TDR News 1–2.
[22]  Crainiceanu C, Diggle P, Rowlingson B (2008) Bivariate Binomial Spatial Modeling of Loa loa Prevalence in Tropical Africa. Journal of the American Statistical Association 103: 21–37. doi: 10.1198/016214507000001409
[23]  Amazigo U (2008) The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 102: Suppl 119–22. doi: 10.1179/136485908X337436
[24]  MDP (2004) Revised Mectizan Expert Committee/Technical Consultative Committee Recommendations for the treatment of onchocerciasis with Mectizan in loiasis endemic areas. Mectizan Donation Programme.
[25]  APOC (2004) Final communiqué of the tenth session of the Joint Action Forum of the African Programme for Onchocerciasis Control. World Health Organisation.
[26]  TDR (2002) Guidelines for rapid assessment of Loa loa. Geneva: UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases. 16 p. TDR/IDE/RAPLOA/02.1 TDR/IDE/RAPLOA/02.1.
[27]  Buck AA, Anderson RI, Sasaki TT, Kawata K (1970) 284 p. Health and disease in Chad: epidemiology, culture and environment in five villages.
[28]  Rhodain F, Rodhain-Rebourg F (1973) A propos de la distribution géographique de la Loase. Médicine et Maladies Infectieuses 3: 429–436. doi: 10.1016/s0399-077x(73)80024-1
[29]  Bregani ER, Balzarini L, Mbaidoum N, Rovellini A (2007) Prevalence of filariasis in symptomatic patients in Moyen Chari district, south of Chad. Trop Doct 37: 175–177. doi: 10.1258/004947507781524629
[30]  Languillon J (1957) Map of filariasis in the Cameroons. Bull Soc Pathol Exot 50: 417–427.
[31]  Mommers EC, Dekker HS, Richard P, Garica A, Chippaux JP (1995) Prevalence of L. loa and M. perstans filariasis in southern Cameroon. Trop Geogr Med 47: 2–5.
[32]  Kamgno J, Boussinesq M (2001) [Hyperendemic loaiasis in the Tikar plain, shrub savanna region of Cameroon]. Bull Soc Pathol Exot 94: 342–346.
[33]  Ripert C, Tchamfong Njabo R, Same Ekobo A (1980) [An epidemiological study of human filariasis : loaiasis, dipetalonemiasis, tetrapetalonemiasis, in Douala fisherman of the river Wouri estuary (Cameroon) (author's transl)]. Rev Epidemiol Sante Publique 28: 331–339.
[34]  Kershaw WE (1951) Studies on the epidemiology of filariasis in West Africa, with special reference to the British Cameroons and the Niger delta. 11. The influence of town and village evolution and development on the incidence of infections with Loa loa and Acanthocheilonema perstans. Ann Trop Med Parasitol 45: 261–283.
[35]  Duke BOL, Moore PJ (1961) Trial of Bancocide as a means of controlling transmission of loiasis on a rubber estate in Nigeria. Ann Trop Med Parasitol 55: 263–277.
[36]  Udonsi JK (1986) The status of human filariasis in relation to clinical signs in endemic areas of the Niger Delta. Ann Trop Med Parasitol 80: 425–432.
[37]  Ouzilleau F (1913) Human filariae in the region of M'Bomou (French Equatorial Africa). Pathology of elephantiasis in this region. The role of Filaria volvulus. Bull Soc Pathol Exot 6: 80–88.
[38]  Fain A, Elsen P, Wery M, Maertens K (1974) Human filariasis in the Mayumble region and adjacent areas (Zaire Republic). Evaluation of the microfilarial density. Ann Soc Belg Med Trop 54: 5–34.
[39]  Fain A (1969) [Geographic distribution of the filaria Loa loa and of the tabanid Chrysops in the Congo and Rwanda]. Ann Soc Belg Med Trop 49: 499–530.
[40]  Addiss D (2010) The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases. Parasit Vectors 3: 100. doi: 10.1186/1756-3305-3-100

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133